ICY:FRA
Incyte
106,25 €
arrow_downward
-1,71%(-1,85) 1D
19. nov., 15.54.47 GMT+1 · EUR
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for ICY...
Åbn
108,25 €
Høj
108,25 €
Lav
106,25 €
Markedsværdi
23,82 mia.
Gns. vol.
63,00
Volumen
30,00
Højeste i 52 uger
115,40 €
Laveste i 52 uger
77,60 €
Antal ansatte
3 t
Åbn
108,25 €
Høj
108,25 €
Lav
106,25 €
Markedsværdi
23,82 mia.
Gns. vol.
63,00
Volumen
30,00
Højeste i 52 uger
115,40 €
Laveste i 52 uger
77,60 €
Antal ansatte
3 t
Nyhedshistorier
Fra webkilder og nyhedspartnere
Barchart.com
·
for 5 timer siden
What Are Wall Street Analysts' Target Price for Incyte Stock?
Investing.com Canada
·
for 19 timer siden
Damora at Jefferies Global Healthcare Conference: CALR push By Investing.com
www.marketscreener.com
·
for 1 dag siden
Incyte Insider Sold Shares Worth $1,292,032, According to a Recent SEC Filing
Investing.com
·
for 2 dage siden
Incyte at UBS Global Biopharma Conference 2026: growth beyond Jakafi
Profil
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
Om Incyte
Administrerende direktør-
Ansatte2,84 t
Grundlagt2002
HovedsædeWilmington, Delaware, USA
SektorHealth Care
Branche-
Websiteincyte.com